Weihua Shen

Lishui University — China

Medicine · Health Sciences

17h-index1.1kcitations272works0.12yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurofibromatosis and Schwannoma Cases(160), Neuroblastoma Research and Treatments(108), Meningioma and schwannoma management(86), Estrogen and related hormone effects(17), Neuroendocrine Tumor Research Advances(13)

Publications272 total

Table S3 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S6 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S1 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S12 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S9 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S7 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S4 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Table S4 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S10 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Table S6 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S13 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S11 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Table S1 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S8 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

Figure S3 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

2025Open Access

A Multiscale Feature Refinement Detector for Small Objects With Ambiguous Boundaries

IEEE Geoscience and Remote Sensing Letters·2025

page 1 of 14Next →

Frequent Co-authors

Shripad V. Bhagwat(15), Melinda D. Willard(11), Alyssa C. Flint(10), Dana K. Mitchell(10), Steven P. Angus(10), Abbi E. Smith(10), Waylan Bessler(10), Li Jiang(10), Henry Mang(10), Xiaohong Li(10), Qingbo Lu(10), Brooke Rodriguez(10), George E. Sandusky(10), Andi R. Masters(10), Chi Zhang(10), Pengtao Dang(10), Jenna Koenig(10), Gary L. Johnson(10), Jiangang Liu(10), Amit Aggarwal(10)